Cognitive dysfunction, affective states, and vulnerability to nicotine addiction: A multifactorial perspective

Frontiers in Psychiatry

Volumn 7, Issue SEP, 2016, Pages

  Besson, Morgane ^a   Forget, Benoît ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Addiction; Cognition; Emotion; Nicotine; Predisposition; Psychiatric disorders

Indexed keywords

ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; COGNITIVE DEFECT; ENDOPHENOTYPE; HUMAN; IMPULSIVENESS; MAJOR DEPRESSION; MOOD DISORDER; NONHUMAN; PERSONALITY; POSTTRAUMATIC STRESS DISORDER; REVIEW; SCHIZOPHRENIA; SENSATION SEEKING; SMOKING; TOBACCO DEPENDENCE;

EID: 84992448374     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2016.00160     Document Type: Review

References (386)

1. Changeux JP. Nicotine addiction and nicotinic receptors: lessons from genetically modified mice. Nat Rev Neurosci (2010) 11:389-401. doi:10.1038/nrn2849
2. Dome P, Lazary J, Kalapos MP, Rihmer Z. Smoking, nicotine and neuropsychiatric disorders. Neurosci Biobehav Rev (2010) 34:295-342. doi:10.1016/j.neubiorev.2009.07.013
3. Anthony JC, Warner LA, Kessler RC. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the national comorbidity survey. Exp Clin Psychopharmacol (1994) 2:244-68. doi:10.1037/1064-1297.2.3.244
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association (2013).
5. Wise RA, Koob GF. The development and maintenance of drug addiction. Neuropsychopharmacology (2014) 39:254-62. doi:10.1038/npp.2013.261
6. Belin-Rauscent A, Fouyssac M, Bonci A, Belin D. How preclinical models evolved to resemble the diagnostic criteria of drug addiction. Biol Psychiatry (2015) 79(1):39-46. doi:10.1016/j.biopsych.2015.01.004
7. Belin D, Belin-Rauscent A, Everitt BJ, Dalley JW. In search of predictive endophenotypes in addiction: insights from preclinical research. Genes Brain Behav (2015) 15(1):74-88. doi:10.1111/gbb.12265
8. Everitt BJ, Robbins TW. Drug addiction: updating actions to habits to compulsions ten years on. Annu Rev Psychol (2015) 67:23-50. doi:10.1146/annurev-psych-122414-033457
9. Koob GF. The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Addiction (2006) 101(Suppl 1):23-30. doi:10.1111/j.1360-0443.2006.01586.x
10. Bardo MT, Neisewander JL, Kelly TH. Individual differences and social influences on the neurobehavioral pharmacology of abused drugs. Pharmacol Rev (2013) 65:255-90. doi:10.1124/pr.111.005124
11. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA (2004) 291:1238-45. doi:10.1001/jama.291.10.1238
12. Audrain-McGovern J, Rodriguez D, Epstein LH, Cuevas J, Rodgers K, Wileyto EP. Does delay discounting play an etiological role in smoking or is it a consequence of smoking? Drug Alcohol Depend (2009) 103:99-106. doi:10.1016/j.drugalcdep.2008.12.019
13. Sheffer CE, Christensen DR, Landes R, Carter LP, Jackson L, Bickel WK. Delay discounting rates: a strong prognostic indicator of smoking relapse. Addict Behav (2014) 39:1682-9. doi:10.1016/j.addbeh.2014.04.019
14. Perkins KA, Lerman C, Coddington SB, Jetton C, Karelitz JL, Scott JA, et al. Initial nicotine sensitivity in humans as a function of impulsivity. Psychopharmacology (Berl) (2008) 200:529-44. doi:10.1007/s00213-008-1231-7
15. Anokhin AP, Golosheykin S. Neural correlates of response inhibition in adolescents prospectively predict regular tobacco smoking. Dev Neuropsychol (2016) 41:22-37. doi:10.1080/87565641.2016.1195833
16. Doran N, McChargue D, Cohen L. Impulsivity and the reinforcing value of cigarette smoking. Addict Behav (2007) 32:90-8. doi:10.1016/j.addbeh.2006.03.023
17. Lipkus IM, Barefoot JC, Williams RB, Siegler IC. Personality measures as predictors of smoking initiation and cessation in the UNC Alumni Heart Study. Health Psychol (1994) 13:149-55. doi:10.1037/0278-6133.13.2.149
18. Audrain-McGovern J, Rodriguez D, Tercyak KP, Cuevas J, Rodgers K, Patterson F. Identifying and characterizing adolescent smoking trajectories. Cancer Epidemiol Biomarkers Prev (2004) 13:2023-34.
19. Kahler CW, Spillane NS, Metrik J, Leventhal AM, Monti PM. Sensation seeking as a predictor of treatment compliance and smoking cessation treatment outcomes in heavy social drinkers. Pharmacol Biochem Behav (2009) 93:285-90. doi:10.1016/j.pbb.2009.01.003
20. Batra A, Collins SE, Schroter M, Eck S, Torchalla I, Buchkremer G. A cluster-randomized effectiveness trial of smoking cessation modified for at-risk smoker subgroups. J Subst Abuse Treat (2010) 38:128-40. doi:10.1016/j.jsat.2009.08.003
21. Fuemmeler BF, Kollins SH, McClernon FJ. Attention deficit hyperactivity disorder symptoms predict nicotine dependence and progression to regular smoking from adolescence to young adulthood. J Pediatr Psychol (2007) 32:1203-13. doi:10.1093/jpepsy/jsm051
22. Tercyak KP, Lerman C, Audrain J. Association of attention-deficit/hyperactivity disorder symptoms with levels of cigarette smoking in a community sample of adolescents. J Am Acad Child Adolesc Psychiatry (2002) 41:799-805. doi:10.1097/00004583-200207000-00011
23. Humfleet GL, Prochaska JJ, Mengis M, Cullen J, Munoz R, Reus V, et al. Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure. Nicotine Tob Res (2005) 7:453-60. doi:10.1080/14622200500125310
24. Lambert NM, Hartsough CS. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J Learn Disabil (1998) 31:533-44. doi:10.1177/002221949803100603
25. Kollins SH, McClernon FJ, Fuemmeler BF. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Arch Gen Psychiatry (2005) 62:1142-7. doi:10.1001/archpsyc.62.10.1142
26. Pomerleau CS, Downey KK, Snedecor SM, Mehringer AM, Marks JL, Pomerleau OF. Smoking patterns and abstinence effects in smokers with no ADHD, childhood ADHD, and adult ADHD symptomatology. Addict Behav (2003) 28:1149-57. doi:10.1016/S0306-4603(02)00223-X
27. McClernon FJ, Van Voorhees EE, English J, Hallyburton M, Holdaway A, Kollins SH. Smoking withdrawal symptoms are more severe among smokers with ADHD and independent of ADHD symptom change: results from a 12-day contingency-managed abstinence trial. Nicotine Tob Res (2011) 13:784-92. doi:10.1093/ntr/ntr073
28. Kollins SH, English JS, Roley ME, O'Brien B, Blair J, Lane SD, et al. Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder. Psychopharmacology (Berl) (2013) 227:19-30. doi:10.1007/s00213-012-2937-0
29. Wilens TE, Vitulano M, Upadhyaya H, Adamson J, Sawtelle R, Utzinger L, et al. Cigarette smoking associated with attention deficit hyperactivity disorder. J Pediatr (2008) 153:414-9. doi:10.1016/j.jpeds.2008.04.030
30. Fergusson DM, Goodwin RD, Horwood LJ. Major depression and cigarette smoking: results of a 21-year longitudinal study. Psychol Med (2003) 33:1357-67. doi:10.1017/S0033291703008596
31. Rohde P, Lewinsohn PM, Brown RA, Gau JM, Kahler CW. Psychiatric disorders, familial factors and cigarette smoking: I. Associations with smoking initiation. Nicotine Tob Res (2003) 5:85-98. doi:10.1080/1462220031000070507
32. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, et al. Smoking, smoking cessation, and major depression. JAMA (1990) 264:1546-9. doi:10.1001/jama.264.12.1546
33. Hitsman B, Papandonatos GD, McChargue DE, DeMott A, Herrera MJ, Spring B, et al. Past major depression and smoking cessation outcome: a systematic review and meta-analysis update. Addiction (2013) 108:294-306. doi:10.1111/add.12009
34. Escobedo LG, Reddy M, Giovino GA. The relationship between depressive symptoms and cigarette smoking in US adolescents. Addiction (1998) 93:433-40. doi:10.1046/j.1360-0443.1998.93343311.x
35. Killen JD, Robinson TN, Haydel KF, Hayward C, Wilson DM, Hammer LD, et al. Prospective study of risk factors for the initiation of cigarette smoking. J Consult Clin Psychol (1997) 65:1011-6. doi:10.1037/0022-006X.65.6.1011
36. Patton GC, Carlin JB, Coffey C, Wolfe R, Hibbert M, Bowes G. Depression, anxiety, and smoking initiation: a prospective study over 3 years. Am J Public Health (1998) 88:1518-22. doi:10.2105/AJPH.88.10.1518
37. Wang MQ, Fitzhugh EC, Green BL, Turner LW, Eddy JM, Westerfield RC. Prospective social-psychological factors of adolescent smoking progression. J Adolesc Health (1999) 24:2-9. doi:10.1016/S1054-139X(98)00080-9
38. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. JAMA (2000) 284:2606-10. doi:10.1001/jama.284.20.2606
39. Ziedonis D, Hitsman B, Beckham JC, Zvolensky M, Adler LE, Audrain-McGovern J, et al. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health Report. Nicotine Tob Res (2008) 10:1691-715. doi:10.1080/14622200802443569
40. Piper ME, Cook JW, Schlam TR, Jorenby DE, Baker TB. Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment. Addiction (2011) 106:418-27. doi:10.1111/j.1360-0443.2010.03173.x
41. Piper ME, Smith SS, Schlam TR, Fleming MF, Bittrich AA, Brown JL, et al. Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation. J Consult Clin Psychol (2010) 78:13-23. doi:10.1037/a0018065
42. Weinberger AH, Desai RA, McKee SA. Nicotine withdrawal in U.S. smokers with current mood, anxiety, alcohol use, and substance use disorders. Drug Alcohol Depend (2010) 108:7-12. doi:10.1016/j.drugalcdep.2009.11.004
43. Beckham JC, Feldman ME, Vrana SR, Mozley SL, Erkanli A, Clancy CP, et al. Immediate antecedents of cigarette smoking in smokers with and without posttraumatic stress disorder: a preliminary study. Exp Clin Psychopharmacol (2005) 13:219-28. doi:10.1037/1064-1297.13.3.219
44. Thorndike FP, Wernicke R, Pearlman MY, Haaga DA. Nicotine dependence, PTSD symptoms, and depression proneness among male and female smokers. Addict Behav (2006) 31:223-31. doi:10.1016/j.addbeh.2005.04.023
45. Feldner MT, Babson KA, Zvolensky MJ. Smoking, traumatic event exposure, and post-traumatic stress: a critical review of the empirical literature. Clin Psychol Rev (2007) 27:14-45. doi:10.1016/j.cpr.2006.08.004
46. Greenberg JB, Ameringer KJ, Trujillo MA, Sun P, Sussman S, Brightman M, et al. Associations between posttraumatic stress disorder symptom clusters and cigarette smoking. Psychol Addict Behav (2012) 26:89-98. doi:10.1037/a0024328
47. Hapke U, Schumann A, Rumpf HJ, John U, Konerding U, Meyer C. Association of smoking and nicotine dependence with trauma and posttraumatic stress disorder in a general population sample. J Nerv Ment Dis (2005) 193:843-6. doi:10.1097/01.nmd.0000188964.83476.e0
48. Beckham JC, Calhoun PS, Dennis MF, Wilson SM, Dedert EA. Predictors of lapse in first week of smoking abstinence in PTSD and non-PTSD smokers. Nicotine Tob Res (2013) 15:1122-9. doi:10.1093/ntr/nts252
49. Dedert EA, Calhoun PS, Harper LA, Dutton CE, McClernon FJ, Beckham JC. Smoking withdrawal in smokers with and without posttraumatic stress disorder. Nicotine Tob Res (2012) 14:372-6. doi:10.1093/ntr/ntr142
50. Evenden JL. Varieties of impulsivity. Psychopharmacology (Berl) (1999) 146:348-61. doi:10.1007/PL00005481
51. de Wit H. Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addict Biol (2009) 14:22-31. doi:10.1111/j.1369-1600.2008.00129.x
52. Lejuez CW, Magidson JF, Mitchell SH, Sinha R, Stevens MC, de Wit H. Behavioral and biological indicators of impulsivity in the development of alcohol use, problems, and disorders. Alcohol Clin Exp Res (2010) 34:1334-45. doi:10.1111/j.1530-0277.2010.01217.x
53. Jupp B, Caprioli D, Dalley JW. Highly impulsive rats: modelling an endophenotype to determine the neurobiological, genetic and environmental mechanisms of addiction. Dis Model Mech (2013) 6:302-11. doi:10.1242/dmm.010934
54. Dalley JW, Everitt BJ, Robbins TW. Impulsivity, compulsivity, and top-down cognitive control. Neuron (2011) 69:680-94. doi:10.1016/j.neuron.2011.01.020
55. Noel X, Van der Linden M, d'Acremont M, Bechara A, Dan B, Hanak C, et al. Alcohol cues increase cognitive impulsivity in individuals with alcoholism. Psychopharmacology (Berl) (2007) 192:291-8. doi:10.1007/s00213-006-0695-6
56. Fillmore MT, Rush CR. Impaired inhibitory control of behavior in chronic cocaine users. Drug Alcohol Depend (2002) 66:265-73. doi:10.1016/S0376-8716(01)00206-X
57. Hester R, Garavan H. Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. J Neurosci (2004) 24:11017-22. doi:10.1523/JNEUROSCI.3321-04.2004
58. Monterosso JR, Aron AR, Cordova X, Xu J, London ED. Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend (2005) 79:273-7. doi:10.1016/j.drugalcdep.2005.02.002
59. Austin AJ, Duka T, Rusted J, Jackson A. Effect of varenicline on aspects of inhibitory control in smokers. Psychopharmacology (Berl) (2014) 231:3771-85. doi:10.1007/s00213-014-3512-7
60. Logemann HN, Bocker KB, Deschamps PK, Kemner C, Kenemans JL. Differences between nicotine-abstinent smokers and non-smokers in terms of visuospatial attention and inhibition before and after single-blind nicotine administration. Neuroscience (2014) 277:375-82. doi:10.1016/j.neuroscience.2014.07.016
61. Harrison EL, Coppola S, McKee SA. Nicotine deprivation and trait impulsivity affect smokers' performance on cognitive tasks of inhibition and attention. Exp Clin Psychopharmacol (2009) 17:91-8. doi:10.1037/a0015657
62. Tsaur S, Strasser AA, Souprountchouk V, Evans GC, Ashare RL. Time dependency of craving and response inhibition during nicotine abstinence. Addict Res Theory (2015) 23:205-12. doi:10.3109/16066359.2014.953940
63. Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. J Clin Psychol (1995) 51:768-74. doi:10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1
64. Verdejo-Garcia A, Lawrence AJ, Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev (2008) 32:777-810. doi:10.1016/j.neubiorev.2007.11.003
65. Cyders MA, Coskunpinar A. Measurement of constructs using self-report and behavioral lab tasks: is there overlap in nomothetic span and construct representation for impulsivity? Clin Psychol Rev (2011) 31:965-82. doi:10.1016/j.cpr.2011.06.001
66. Bickel WK, Odum AL, Madden GJ. Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers. Psychopharmacology (Berl) (1999) 146:447-54. doi:10.1007/PL00005490
67. Johnson MW, Bickel WK, Baker F. Moderate drug use and delay discounting: a comparison of heavy, light, and never smokers. Exp Clin Psychopharmacol (2007) 15:187-94. doi:10.1037/1064-1297.15.2.187
68. Carim-Todd L, Mitchell SH, Oken BS. Impulsivity and stress response in nondependent smokers (tobacco chippers) in comparison to heavy smokers and nonsmokers. Nicotine Tob Res (2015) 18(5):547-56. doi:10.1093/ntr/ntv210
69. Zuckerman M, Bone RN, Neary R, Mangelsdorff D, Brustman B. What is the sensation seeker? Personality trait and experience correlates of the Sensation-Seeking Scales. J Consult Clin Psychol (1972) 39:308-21. doi:10.1037/h0033398
70. Cloninger CR. A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry (1987) 44:573-88. doi:10.1001/archpsyc.1987.01800180093014
71. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry (1993) 50:975-90. doi:10.1001/archpsyc.1993.01820240059008
72. Stallings MC, Hewitt JK, Cloninger CR, Heath AC, Eaves LJ. Genetic and environmental structure of the Tridimensional Personality Questionnaire: three or four temperament dimensions? J Pers Soc Psychol (1996) 70:127-40. doi:10.1037/0022-3514.70.1.127
73. Peritogiannis V. Sensation/novelty seeking in psychotic disorders: a review of the literature. World J Psychiatry (2015) 5:79-87. doi:10.5498/wjp.v5.i1.79
74. Kosten TA, Ball SA, Rounsaville BJ. A sibling study of sensation seeking and opiate addiction. J Nerv Ment Dis (1994) 182:284-9. doi:10.1097/00005053-199405000-00006
75. Wills TA, Windle M, Cleary SD. Temperament and novelty seeking in adolescent substance use: convergence of dimensions of temperament with constructs from Cloninger's theory. J Pers Soc Psychol (1998) 74:387-406. doi:10.1037/0022-3514.74.2.387
76. Cloninger CR, Przybeck TR, Svrakic DM. The tridimensional personality questionnaire: U.S. normative data. Psychol Rep (1991) 69:1047-57. doi:10.2466/pr0.1991.69.3.1047
77. Zuckerman M, Cloninger CR. Relationships between Cloninger's, Zuckerman's, and Eysenck's dimensions of personality. Pers Individ Dif (1996) 21:283-5. doi:10.1016/0191-8869(96)00042-6
78. Wills TA, Vaccaro D, McNamara G. Novelty seeking, risk taking, and related constructs as predictors of adolescent substance use: an application of Cloninger's theory. J Subst Abuse (1994) 6:1-20. doi:10.1016/S0899-3289(94)90039-6
79. Masse LC, Tremblay RE. Behavior of boys in kindergarten and the onset of substance use during adolescence. Arch Gen Psychiatry (1997) 54:62-8. doi:10.1001/archpsyc.1997.01830130068014
80. Sargent JD, Tanski S, Stoolmiller M, Hanewinkel R. Using sensation seeking to target adolescents for substance use interventions. Addiction (2010) 105:506-14. doi:10.1111/j.1360-0443.2009.02782.x
81. Etter JF, Pelissolo A, Pomerleau C, De Saint-Hilaire Z. Associations between smoking and heritable temperament traits. Nicotine Tob Res (2003) 5:401-9. doi:10.1080/1462220031000094240
82. Perkins KA, Gerlach D, Broge M, Grobe JE, Wilson A. Greater sensitivity to subjective effects of nicotine in nonsmokers high in sensation seeking. Exp Clin Psychopharmacol (2000) 8:462-71. doi:10.1037/1064-1297.8.4.462
83. Barkley RA. Issues in the diagnosis of attention-deficit/hyperactivity disorder in children. Brain Dev (2003) 25:77-83. doi:10.1016/S0387-7604(02)00152-3
84. Barbaresi WJ, Katusic SK, Colligan RC, Pankratz VS, Weaver AL, Weber KJ, et al. How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn. Arch Pediatr Adolesc Med (2002) 156:217-24. doi:10.1001/archpedi.156.3.217
85. Barbaresi W, Katusic S, Colligan R, Weaver A, Pankratz V, Mrazek D, et al. How common is attention-deficit/hyperactivity disorder? Towards resolution of the controversy: results from a population-based study. Acta Paediatr Suppl (2004) 93:55-9. doi:10.1111/j.1651-2227.2004.tb03058.x
86. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry (2006) 163:716-23. doi:10.1176/ajp.2006.163.4.716
87. Elkins IJ, McGue M, Iacono WG. Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Arch Gen Psychiatry (2007) 64:1145-52. doi:10.1001/archpsyc.64.10.1145
88. Hartsough CS, Lambert NM. Pattern and progression of drug use among hyperactives and controls: a prospective short-term longitudinal study. J Child Psychol Psychiatry (1987) 28:543-53. doi:10.1111/j.1469-7610.1987.tb00222.x
89. Biederman J, Monuteaux MC, Mick E, Wilens TE, Fontanella JA, Poetzl KM, et al. Is cigarette smoking a gateway to alcohol and illicit drug use disorders? A study of youths with and without attention deficit hyperactivity disorder. Biol Psychiatry (2006) 59:258-64. doi:10.1016/j.biopsych.2005.07.009
90. Rukstalis M, Jepson C, Patterson F, Lerman C. Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy. J Subst Abuse Treat (2005) 28:297-304. doi:10.1016/j.jsat.2005.02.002
91. Linnet KM, Dalsgaard S, Obel C, Wisborg K, Henriksen TB, Rodriguez A, et al. Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am J Psychiatry (2003) 160:1028-40. doi:10.1176/appi.ajp.160.6.1028
92. Langley K, Rice F, van den Bree MB, Thapar A. Maternal smoking during pregnancy as an environmental risk factor for attention deficit hyperactivity disorder behaviour. A review. Minerva Pediatr (2005) 57:359-71.
93. Rodriguez A, Bohlin G. Are maternal smoking and stress during pregnancy related to ADHD symptoms in children? J Child Psychol Psychiatry (2005) 46:246-54. doi:10.1111/j.1469-7610.2004.00359.x
94. Banerjee TD, Middleton F, Faraone SV. Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr (2007) 96:1269-74. doi:10.1111/j.1651-2227.2007.00430.x
95. Motlagh MG, Sukhodolsky DG, Landeros-Weisenberger A, Katsovich L, Thompson N, Scahill L, et al. Adverse effects of heavy prenatal maternal smoking on attentional control in children with ADHD. J Atten Disord (2011) 15:593-603. doi:10.1177/1087054710374576
96. Knopik VS. Maternal smoking during pregnancy and child outcomes: real or spurious effect? Dev Neuropsychol (2009) 34:1-36. doi:10.1080/87565640802564366
97. Thapar A, Rice F, Hay D, Boivin J, Langley K, van den Bree M, et al. Prenatal smoking might not cause attention-deficit/hyperactivity disorder: evidence from a novel design. Biol Psychiatry (2009) 66:722-7. doi:10.1016/j.biopsych.2009.05.032
98. Skoglund C, Chen Q, D'Onofrio BM, Lichtenstein P, Larsson H. Familial confounding of the association between maternal smoking during pregnancy and ADHD in offspring. J Child Psychol Psychiatry (2014) 55:61-8. doi:10.1111/jcpp.12124
99. Obel C, Zhu JL, Olsen J, Breining S, Li J, Gronborg TK, et al. The risk of attention deficit hyperactivity disorder in children exposed to maternal smoking during pregnancy-a reexamination using a sibling design. J Child Psychol Psychiatry (2015) 57(4):532-7. doi:10.1111/jcpp.12478
100. Treur JL, Willemsen G, Bartels M, Geels LM, van Beek JH, Huppertz C, et al. Smoking during adolescence as a risk factor for attention problems. Biol Psychiatry (2015) 78:656-63. doi:10.1016/j.biopsych.2014.06.019
101. Kutlu MG, Parikh V, Gould TJ. Nicotine addiction and psychiatric disorders. Int Rev Neurobiol (2015) 124:171-208. doi:10.1016/bs.irn.2015.08.004
102. Tidey JW, Miller ME. Smoking cessation and reduction in people with chronic mental illness. BMJ (2015) 351:h4065. doi:10.1136/bmj.h4065
103. Audrain-McGovern J, Rodriguez D, Kassel JD. Adolescent smoking and depression: evidence for self-medication and peer smoking mediation. Addiction (2009) 104:1743-56. doi:10.1111/j.1360-0443.2009.02617.x
104. Hooshmand S, Willoughby T, Good M. Does the direction of effects in the association between depressive symptoms and health-risk behaviors differ by behavior? A longitudinal study across the high school years. J Adolesc Health (2012) 50:140-7. doi:10.1016/j.jadohealth.2011.05.016
105. Berlin I, Covey LS. Pre-cessation depressive mood predicts failure to quit smoking: the role of coping and personality traits. Addiction (2006) 101:1814-21. doi:10.1111/j.1360-0443.2006.01616.x
106. Strong DR, Kahler CW, Leventhal AM, Abrantes AM, Lloyd-Richardson E, Niaura R, et al. Impact of bupropion and cognitive-behavioral treatment for depression on positive affect, negative affect, and urges to smoke during cessation treatment. Nicotine Tob Res (2009) 11:1142-53. doi:10.1093/ntr/ntp111
107. Choi WS, Patten CA, Gillin JC, Kaplan RM, Pierce JP. Cigarette smoking predicts development of depressive symptoms among U.S. adolescents. Ann Behav Med (1997) 19:42-50. doi:10.1007/BF02883426
108. Wu LT, Anthony JC. Tobacco smoking and depressed mood in late childhood and early adolescence. Am J Public Health (1999) 89:1837-40. doi:10.2105/AJPH.89.12.1837
109. Goodman E, Capitman J. Depressive symptoms and cigarette smoking among teens. Pediatrics (2000) 106:748-55. doi:10.1542/peds.106.4.748
110. Klungsoyr O, Nygard JF, Sorensen T, Sandanger I. Cigarette smoking and incidence of first depressive episode: an 11-year, population-based follow-up study. Am J Epidemiol (2006) 163:421-32. doi:10.1093/aje/kwj058
111. Steuber TL, Danner F. Adolescent smoking and depression: which comes first? Addict Behav (2006) 31:133-6. doi:10.1016/j.addbeh.2005.04.010
112. Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, Aveyard P. Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ (2014) 348:g1151. doi:10.1136/bmj.g1151
113. Ischaki E, Gratziou C. Smoking and depression: is smoking cessation effective? Ther Adv Respir Dis (2009) 3:31-8. doi:10.1177/1753465809102662
114. Chaiton MO, Cohen JE, O'Loughlin J, Rehm J. A systematic review of longitudinal studies on the association between depression and smoking in adolescents. BMC Public Health (2009) 9:356. doi:10.1186/1471-2458-9-356
115. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 62:593-602. doi:10.1001/archpsyc.62.6.593
116. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 62:617-27. doi:10.1001/archpsyc.62.6.617
117. Cook BL, Wayne GF, Kafali EN, Liu Z, Shu C, Flores M. Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation. JAMA (2014) 311:172-82. doi:10.1001/jama.2013.284985
118. Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry (2004) 61:1107-15. doi:10.1001/archpsyc.61.11.1107
119. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry (1995) 52:1048-60. doi:10.1001/archpsyc.1995.03950240066012
120. Breslau N, Davis GC, Schultz LR. Posttraumatic stress disorder and the incidence of nicotine, alcohol, and other drug disorders in persons who have experienced trauma. Arch Gen Psychiatry (2003) 60:289-94. doi:10.1001/archpsyc.60.3.289
121. Breslau N, Novak SP, Kessler RC. Psychiatric disorders and stages of smoking. Biol Psychiatry (2004) 55:69-76. doi:10.1016/S0006-3223(03)00317-2
122. Goodwin RD, Lewinsohn PM, Seeley JR. Cigarette smoking and panic attacks among young adults in the community: the role of parental smoking and anxiety disorders. Biol Psychiatry (2005) 58:686-93. doi:10.1016/j.biopsych.2005.04.042
123. Koenen KC, Hitsman B, Lyons MJ, Niaura R, McCaffery J, Goldberg J, et al. A twin registry study of the relationship between posttraumatic stress disorder and nicotine dependence in men. Arch Gen Psychiatry (2005) 62:1258-65. doi:10.1001/archpsyc.62.11.1258
124. Moylan S, Jacka FN, Pasco JA, Berk M. Cigarette smoking, nicotine dependence and anxiety disorders: a systematic review of population-based, epidemiological studies. BMC Med (2012) 10:123. doi:10.1186/1741-7015-10-123
125. Jiang F, Li S, Pan L, Zhang N, Jia C. Association of anxiety disorders with the risk of smoking behaviors: a meta-analysis of prospective observational studies. Drug Alcohol Depend (2014) 145:69-76. doi:10.1016/j.drugalcdep.2014.10.022
126. Siru R, Hulse GK, Tait RJ. Assessing motivation to quit smoking in people with mental illness: a review. Addiction (2009) 104:719-33. doi:10.1111/j.1360-0443.2009.02545.x
127. Zehe JM, Colder CR, Read JP, Wieczorek WF, Lengua LJ. Social and generalized anxiety symptoms and alcohol and cigarette use in early adolescence: the moderating role of perceived peer norms. Addict Behav (2013) 38:1931-9. doi:10.1016/j.addbeh.2012.11.013
128. Breslau N, Novak SP, Kessler RC. Daily smoking and the subsequent onset of psychiatric disorders. Psychol Med (2004) 34:323-33. doi:10.1017/S0033291703008869
129. Feldner MT, Babson KA, Zvolensky MJ, Vujanovic AA, Lewis SF, Gibson LE, et al. Posttraumatic stress symptoms and smoking to reduce negative affect: an investigation of trauma-exposed daily smokers. Addict Behav (2007) 32:214-27. doi:10.1016/j.addbeh.2006.03.032
130. Fu SS, McFall M, Saxon AJ, Beckham JC, Carmody TP, Baker DG, et al. Post-traumatic stress disorder and smoking: a systematic review. Nicotine Tob Res (2007) 9:1071-84. doi:10.1080/14622200701488418
131. Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophr Res (2008) 102:1-18. doi:10.1016/j.schres.2008.04.011
132. Morisano D, Bacher I, Audrain-McGovern J, George TP. Mechanisms underlying the comorbidity of tobacco use in mental health and addictive disorders. Can J Psychiatry (2009) 54:356-67.
133. Olincy A, Young DA, Freedman R. Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biol Psychiatry (1997) 42:1-5. doi:10.1016/S0006-3223(96)00302-2
134. Weinberger AH, Sacco KA, Creeden CL, Vessicchio JC, Jatlow PI, George TP. Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia. Schizophr Res (2007) 91:217-25. doi:10.1016/j.schres.2006.12.007
135. Williams JM, Gandhi KK, Lu SE, Kumar S, Shen J, Foulds J, et al. Higher nicotine levels in schizophrenia compared with controls after smoking a single cigarette. Nicotine Tob Res (2010) 12:855-9. doi:10.1093/ntr/ntq102
136. Williams JM, Ziedonis DM, Abanyie F, Steinberg ML, Foulds J, Benowitz NL. Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect. Schizophr Res (2005) 79:323-35. doi:10.1016/j.schres.2005.04.016
137. Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM. Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls. Drug Alcohol Depend (2005) 80:259-65. doi:10.1016/j.drugalcdep.2005.04.002
138. MacKillop J, Tidey JW. Cigarette demand and delayed reward discounting in nicotine-dependent individuals with schizophrenia and controls: an initial study. Psychopharmacology (Berl) (2011) 216:91-9. doi:10.1007/s00213-011-2185-8
139. Winterer G. Why do patients with schizophrenia smoke? Curr Opin Psychiatry (2010) 23:112-9. doi:10.1097/YCO.0b013e3283366643
140. Lawrence NS, Ross TJ, Stein EA. Cognitive mechanisms of nicotine on visual attention. Neuron (2002) 36:539-48. doi:10.1016/S0896-6273(02)01004-8
141. Hong LE, Schroeder M, Ross TJ, Buchholz B, Salmeron BJ, Wonodi I, et al. Nicotine enhances but does not normalize visual sustained attention and the associated brain network in schizophrenia. Schizophr Bull (2011) 37:416-25. doi:10.1093/schbul/sbp089
142. Warbrick T, Mobascher A, Brinkmeyer J, Musso F, Stoecker T, Shah NJ, et al. Nicotine effects on brain function during a visual oddball task: a comparison between conventional and EEG-informed fMRI analysis. J Cogn Neurosci (2012) 24:1682-94. doi:10.1162/jocn_a_00236
143. Rusted JM, Trawley S. Comparable effects of nicotine in smokers and nonsmokers on a prospective memory task. Neuropsychopharmacology (2006) 31:1545-9. doi:10.1038/sj.npp.1300965
144. Jansari AS, Froggatt D, Edginton T, Dawkins L. Investigating the impact of nicotine on executive functions using a novel virtual reality assessment. Addiction (2013) 108:977-84. doi:10.1111/add.12082
145. Barr RS, Culhane MA, Jubelt LE, Mufti RS, Dyer MA, Weiss AP, et al. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology (2008) 33:480-90. doi:10.1038/sj.npp.1301423
146. Hong LE, Wonodi I, Lewis J, Thaker GK. Nicotine effect on prepulse inhibition and prepulse facilitation in schizophrenia patients. Neuropsychopharmacology (2008) 33:2167-74. doi:10.1038/sj.npp.1301601
147. Postma P, Gray JA, Sharma T, Geyer M, Mehrotra R, Das M, et al. A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia. Psychopharmacology (Berl) (2006) 184:589-99. doi:10.1007/s00213-006-0307-5
148. Conners CK, Levin ED, Sparrow E, Hinton SC, Erhardt D, Meck WH, et al. Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). Psychopharmacol Bull (1996) 32:67-73.
149. Levin ED, Conners CK, Sparrow E, Hinton SC, Erhardt D, Meck WH, et al. Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl) (1996) 123:55-63. doi:10.1007/BF02246281
150. Bekker EM, Bocker KB, Van Hunsel F, van den Berg MC, Kenemans JL. Acute effects of nicotine on attention and response inhibition. Pharmacol Biochem Behav (2005) 82:539-48. doi:10.1016/j.pbb.2005.10.009
151. Potter AS, Newhouse PA. Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl) (2004) 176:182-94. doi:10.1007/s00213-004-1874-y
152. Potter AS, Newhouse PA. Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder. Pharmacol Biochem Behav (2008) 88:407-17. doi:10.1016/j.pbb.2007.09.014
153. Potter AS, Bucci DJ, Newhouse PA. Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivity. Psychopharmacology (Berl) (2012) 220:331-40. doi:10.1007/s00213-011-2476-0
154. Salin-Pascual RJ, Rosas M, Jimenez-Genchi A, Rivera-Meza BL, Delgado-Parra V. Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression. J Clin Psychiatry (1996) 57:387-9.
155. Salin-Pascual RJ, Basanez-Villa E. Changes in compulsion and anxiety symptoms with nicotine transdermal patches in non-smoking obsessive-compulsive disorder patients. Rev Invest Clin (2003) 55:650-4.
156. Heishman SJ, Kleykamp BA, Singleton EG. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl) (2010) 210:453-69. doi:10.1007/s00213-010-1848-1
157. Levin ED, McClernon FJ, Rezvani AH. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) (2006) 184:523-39. doi:10.1007/s00213-005-0164-7
158. D'Souza MS, Markou A. Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits. Neuropharmacology (2012) 62:1564-73. doi:10.1016/j.neuropharm.2011.01.044
159. Kalmijn S, van Boxtel MP, Verschuren MW, Jolles J, Launer LJ. Cigarette smoking and alcohol consumption in relation to cognitive performance in middle age. Am J Epidemiol (2002) 156:936-44. doi:10.1093/aje/kwf135
160. Richards M, Jarvis MJ, Thompson N, Wadsworth ME. Cigarette smoking and cognitive decline in midlife: evidence from a prospective birth cohort study. Am J Public Health (2003) 93:994-8. doi:10.2105/AJPH.93.6.994
161. Anstey KJ, von Sanden C, Salim A, O'Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol (2007) 166:367-78. doi:10.1093/aje/kwm116
162. Ernst M, Heishman SJ, Spurgeon L, London ED. Smoking history and nicotine effects on cognitive performance. Neuropsychopharmacology (2001) 25:313-9. doi:10.1016/S0893-133X(01)00257-3
163. Hahn B, Ross TJ, Yang Y, Kim I, Huestis MA, Stein EA. Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network. J Neurosci (2007) 27:3477-89. doi:10.1523/JNEUROSCI.5129-06.2007
164. Burke JD, Loeber R, Lahey BB. Which aspects of ADHD are associated with tobacco use in early adolescence? J Child Psychol Psychiatry (2001) 42:493-502. doi:10.1111/1469-7610.00743
165. Lerman C, Audrain J, Tercyak K, Hawk LW Jr, Bush A, Crystal-Mansour S, et al. Attention-Deficit Hyperactivity Disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program. Nicotine Tob Res (2001) 3:353-9. doi:10.1080/14622200110072156
166. George TP, Vessicchio JC, Termine A, Sahady DM, Head CA, Pepper WT, et al. Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology (2002) 26:75-85. doi:10.1016/S0893-133X(01)00296-2
167. Sacco KA, Termine A, Seyal A, Dudas MM, Vessicchio JC, Krishnan-Sarin S, et al. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry (2005) 62:649-59. doi:10.1001/archpsyc.62.6.649
168. Foulds J, Stapleton J, Swettenham J, Bell N, McSorley K, Russell MA. Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology (Berl) (1996) 127:31-8. doi:10.1007/BF02805972
169. Grobe JE, Perkins KA, Goettler-Good J, Wilson A. Importance of environmental distractors in the effects of nicotine on short-term memory. Exp Clin Psychopharmacol (1998) 6:209-16. doi:10.1037/1064-1297.6.2.209
170. Xu J, Mendrek A, Cohen MS, Monterosso J, Rodriguez P, Simon SL, et al. Brain activity in cigarette smokers performing a working memory task: effect of smoking abstinence. Biol Psychiatry (2005) 58:143-50. doi:10.1016/j.biopsych.2005.03.028
171. Niemegeers P, Dumont GJ, Quisenaerts C, Morrens M, Boonzaier J, Fransen E, et al. The effects of nicotine on cognition are dependent on baseline performance. Eur Neuropsychopharmacol (2014) 24:1015-23. doi:10.1016/j.euroneuro.2014.03.011
172. Kleykamp BA, Jennings JM, Blank MD, Eissenberg T. The effects of nicotine on attention and working memory in never-smokers. Psychol Addict Behav (2005) 19:433-8. doi:10.1037/0893-164X.19.4.433
173. Poltavski DV, Petros T. Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits. Physiol Behav (2006) 87:614-24. doi:10.1016/j.physbeh.2005.12.011
174. Lejuez CW, Aklin WM, Jones HA, Richards JB, Strong DR, Kahler CW, et al. The Balloon Analogue Risk Task (BART) differentiates smokers and nonsmokers. Exp Clin Psychopharmacol (2003) 11:26-33. doi:10.1037/1064-1297.11.1.26
175. Galvan A, Schonberg T, Mumford J, Kohno M, Poldrack RA, London ED. Greater risk sensitivity of dorsolateral prefrontal cortex in young smokers than in nonsmokers. Psychopharmacology (Berl) (2013) 229:345-55. doi:10.1007/s00213-013-3113-x
176. Briggs Z, O'Connor M, Jollans EK, O'Halloran L, Dymond S, Whelan R. Flexible emotion-based decision-making behavior varies in current and former smokers. Addict Behav (2015) 45:269-75. doi:10.1016/j.addbeh.2015.02.011
177. Wei Z, Yang N, Liu Y, Yang L, Wang Y, Han L, et al. Resting-state functional connectivity between the dorsal anterior cingulate cortex and thalamus is associated with risky decision-making in nicotine addicts. Sci Rep (2016) 6:21778. doi:10.1038/srep21778
178. Braff DL. Information processing and attention dysfunctions in schizophrenia. Schizophr Bull (1993) 19:233-59. doi:10.1093/schbul/19.2.233
179. Andreasen NC. Schizophrenia: the fundamental questions. Brain Res Brain Res Rev (2000) 31:106-12. doi:10.1016/S0165-0173(99)00027-2
180. Adler LE, Pachtman E, Franks RD, Pecevich M, Waldo MC, Freedman R. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry (1982) 17:639-54.
181. Adler LE, Hoffer LD, Wiser A, Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry (1993) 150:1856-61. doi:10.1176/ajp.150.12.1856
182. Adler LE, Hoffer LJ, Griffith J, Waldo MC, Freedman R. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol Psychiatry (1992) 32:607-16. doi:10.1016/0006-3223(92)90073-9
183. Knott V, Millar A, Fisher D, Albert P. Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism. Neuroscience (2010) 166:145-56. doi:10.1016/j.neuroscience.2009.11.053
184. Millar A, Smith D, Choueiry J, Fisher D, Albert P, Knott V. The moderating role of the dopamine transporter 1 gene on P50 sensory gating and its modulation by nicotine. Neuroscience (2011) 180:148-56. doi:10.1016/j.neuroscience.2011.02.008
185. Braff DL, Grillon C, Geyer MA. Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry (1992) 49:206-15. doi:10.1001/archpsyc.1992.01820030038005
186. Woznica AA, Sacco KA, George TP. Prepulse inhibition deficits in schizophrenia are modified by smoking status. Schizophr Res (2009) 112:86-90. doi:10.1016/j.schres.2009.04.016
187. Reynolds B, Richards JB, Horn K, Karraker K. Delay discounting and probability discounting as related to cigarette smoking status in adults. Behav Processes (2004) 65:35-42. doi:10.1016/S0376-6357(03)00109-8
188. Ohmura Y, Takahashi T, Kitamura N. Discounting delayed and probabilistic monetary gains and losses by smokers of cigarettes. Psychopharmacology (Berl) (2005) 182:508-15. doi:10.1007/s00213-005-0110-8
189. Markou A, Kosten TR, Koob GF. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology (1998) 18:135-74. doi:10.1016/S0893-133X(97)00113-9
190. Schleicher HE, Harris KJ, Catley D, Nazir N. The role of depression and negative affect regulation expectancies in tobacco smoking among college students. J Am Coll Health (2009) 57:507-12. doi:10.3200/JACH.57.5.507-512
191. Salin-Pascual RJ, de la Fuente JR, Galicia-Polo L, Drucker-Colin R. Effects of transderman nicotine on mood and sleep in nonsmoking major depressed patients. Psychopharmacology (Berl) (1995) 121:476-9. doi:10.1007/BF02246496
192. Pidoplichko VI, DeBiasi M, Williams JT, Dani JA. Nicotine activates and desensitizes midbrain dopamine neurons. Nature (1997) 390:401-4. doi:10.1038/37120
193. Reitstetter R, Lukas RJ, Gruener R. Dependence of nicotinic acetylcholine receptor recovery from desensitization on the duration of agonist exposure. J Pharmacol Exp Ther (1999) 289:656-60.
194. Shytle RD, Silver AA, Sanberg PR. Comorbid bipolar disorder in Tourette's syndrome responds to the nicotinic receptor antagonist mecamylamine (Inversine). Biol Psychiatry (2000) 48:1028-31. doi:10.1016/S0006-3223(00)00945-8
195. Silver AA, Shytle RD, Sanberg PR. Mecamylamine in Tourette's syndrome: a two-year retrospective case study. J Child Adolesc Psychopharmacol (2000) 10:59-68. doi:10.1089/cap.2000.10.59
196. Silver AA, Shytle RD, Sheehan KH, Sheehan DV, Ramos A, Sanberg PR. Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder. J Am Acad Child Adolesc Psychiatry (2001) 40:1103-10. doi:10.1097/00004583-200109000-00020
197. Shytle RD, Silver AA, Sheehan KH, Sheehan DV, Sanberg PR. Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine. Depress Anxiety (2002) 16:89-92. doi:10.1002/da.10035
198. George TP, Sacco KA, Vessicchio JC, Weinberger AH, Shytle RD. Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary study. J Clin Psychopharmacol (2008) 28:340-4. doi:10.1097/JCP.0b013e318172b49e
199. Beckham JC, Kirby AC, Feldman ME, Hertzberg MA, Moore SD, Crawford AL, et al. Prevalence and correlates of heavy smoking in Vietnam veterans with chronic posttraumatic stress disorder. Addict Behav (1997) 22:637-47. doi:10.1016/S0306-4603(96)00071-8
200. Calhoun PS, Bosworth HB, Siegler IC, Bastian LA. The relationship between hostility and behavioral risk factors for poor health in women veterans. Prev Med (2001) 33:552-7. doi:10.1006/pmed.2001.0921
201. Marshall EC, Zvolensky MJ, Vujanovic AA, Gibson LE, Gregor K, Bernstein A. Evaluation of smoking characteristics among community-recruited daily smokers with and without posttraumatic stress disorder and panic psychopathology. J Anxiety Disord (2008) 22:1214-26. doi:10.1016/j.janxdis.2008.01.003
202. Carmody TP, McFall M, Saxon AJ, Malte CA, Chow B, Joseph AM, et al. Smoking outcome expectancies in military veteran smokers with posttraumatic stress disorder. Nicotine Tob Res (2012) 14:919-26. doi:10.1093/ntr/ntr304
203. Dedert EA, Dennis PA, Swinkels CM, Calhoun PS, Dennis MF, Beckham JC. Ecological momentary assessment of posttraumatic stress disorder symptoms during a smoking quit attempt. Nicotine Tob Res (2014) 16:430-6. doi:10.1093/ntr/ntt167
204. Jupp B, Dalley JW. Behavioral endophenotypes of drug addiction: etiological insights from neuroimaging studies. Neuropharmacology (2014) 76 Pt B:487-97. doi:10.1016/j.neuropharm.2013.05.041
205. Falco AM, Bevins RA. Individual differences in the behavioral effects of nicotine: a review of the preclinical animal literature. Pharmacol Biochem Behav (2015) 138:80-90. doi:10.1016/j.pbb.2015.09.017
206. Diergaarde L, Pattij T, Poortvliet I, Hogenboom F, de Vries W, Schoffelmeer AN, et al. Impulsive choice and impulsive action predict vulnerability to distinct stages of nicotine seeking in rats. Biol Psychiatry (2008) 63:301-8. doi:10.1016/j.biopsych.2007.07.011
207. Diergaarde L, van Mourik Y, Pattij T, Schoffelmeer AN, De Vries TJ. Poor impulse control predicts inelastic demand for nicotine but not alcohol in rats. Addict Biol (2012) 17:576-87. doi:10.1111/j.1369-1600.2011.00376.x
208. Kolokotroni KZ, Rodgers RJ, Harrison AA. Trait differences in response to chronic nicotine and nicotine withdrawal in rats. Psychopharmacology (Berl) (2014) 231:567-80. doi:10.1007/s00213-013-3270-y
209. Suto N, Austin JD, Vezina P. Locomotor response to novelty predicts a rat's propensity to self-administer nicotine. Psychopharmacology (Berl) (2001) 158:175-80. doi:10.1007/s002130100867
210. Guillem K, Vouillac C, Azar MR, Parsons LH, Koob GF, Cador M, et al. Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats. J Neurosci (2005) 25:8593-600. doi:10.1523/JNEUROSCI.2139-05.2005
211. Bernardi RE, Spanagel R. Basal activity level in mice predicts the initial and sensitized locomotor response to nicotine only in high responders. Behav Brain Res (2014) 264:143-50. doi:10.1016/j.bbr.2014.01.046
212. Pastor V, Andres ME, Bernabeu RO. The effect of previous exposure to nicotine on nicotine place preference. Psychopharmacology (Berl) (2013) 226:551-60. doi:10.1007/s00213-012-2928-1
213. Aydin C, Oztan O, Isgor C. Vulnerability to nicotine abstinence-related social anxiety-like behavior: molecular correlates in neuropeptide Y, Y2 receptor and corticotropin releasing factor. Neurosci Lett (2011) 490:220-5. doi:10.1016/j.neulet.2010.12.056
214. Aydin C, Oztan O, Isgor C. Long-term effects of juvenile nicotine exposure on abstinence-related social anxiety-like behavior and amygdalar cannabinoid receptor 1 (CB1R) mRNA expression in the novelty-seeking phenotype. Behav Brain Res (2012) 228:236-9. doi:10.1016/j.bbr.2011.11.015
215. Aydin C, Oztan O, Isgor C. Nicotine-induced anxiety-like behavior in a rat model of the novelty-seeking phenotype is associated with long-lasting neuropeptidergic and neuroplastic adaptations in the amygdala: effects of the cannabinoid receptor 1 antagonist AM251. Neuropharmacology (2012) 63:1335-45. doi:10.1016/j.neuropharm.2012.08.016
216. Aydin C, Oztan O, Isgor C. Hippocampal Y2 receptor-mediated mossy fiber plasticity is implicated in nicotine abstinence-related social anxiety-like behavior in an outbred rat model of the novelty-seeking phenotype. Pharmacol Biochem Behav (2014) 125:48-54. doi:10.1016/j.pbb.2014.08.004
217. Pawlak CR, Schwarting RK. Object preference and nicotine consumption in rats with high vs. low rearing activity in a novel open field. Pharmacol Biochem Behav (2002) 73:679-87. doi:10.1016/S0091-3057(02)00852-3
218. Pawlak CR, Schwarting RK. Repeated nicotine treatment in rats with high versus low rearing activity: analyses of behavioural sensitisation and place preference. Psychopharmacology (Berl) (2005) 178:440-50. doi:10.1007/s00213-004-2024-2
219. Wang T, Han W, Wang B, Jiang Q, Solberg-Woods LC, Palmer AA, et al. Propensity for social interaction predicts nicotine-reinforced behaviors in outbred rats. Genes Brain Behav (2014) 13:202-12. doi:10.1111/gbb.12112
220. Abreu-Villaca Y, Queiroz-Gomes Fdo E, Dal Monte AP, Filgueiras CC, Manhaes AC. Individual differences in novelty-seeking behavior but not in anxiety response to a new environment can predict nicotine consumption in adolescent C57BL/6 mice. Behav Brain Res (2006) 167:175-82. doi:10.1016/j.bbr.2005.09.003
221. Manhaes AC, Guthierrez MC, Filgueiras CC, Abreu-Villaca Y. Anxiety-like behavior during nicotine withdrawal predict subsequent nicotine consumption in adolescent C57BL/6 mice. Behav Brain Res (2008) 193:216-24. doi:10.1016/j.bbr.2008.05.018
222. Falco AM, McDonald CG, Smith RF. Anxiety status affects nicotine-and baclofen-induced locomotor activity, anxiety, and single-trial conditioned place preference in male adolescent rats. Dev Psychobiol (2014) 56:1352-64. doi:10.1002/dev.21217
223. Bilkei-Gorzo A, Racz I, Michel K, Darvas M, Maldonado R, Zimmer A. A common genetic predisposition to stress sensitivity and stress-induced nicotine craving. Biol Psychiatry (2008) 63:164-71. doi:10.1016/j.biopsych.2007.02.010
224. Gomez R, Corr PJ. ADHD and personality: a meta-analytic review. Clin Psychol Rev (2014) 34:376-88. doi:10.1016/j.cpr.2014.05.002
225. Lombardo LE, Bearden CE, Barrett J, Brumbaugh MS, Pittman B, Frangou S, et al. Trait impulsivity as an endophenotype for bipolar I disorder. Bipolar Disord (2012) 14:565-70. doi:10.1111/j.1399-5618.2012.01035.x
226. Kreek MJ, Nielsen DA, Butelman ER, LaForge KS. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci (2005) 8:1450-7. doi:10.1038/nn1583
227. Ersche KD, Turton AJ, Pradhan S, Bullmore ET, Robbins TW. Drug addiction endophenotypes: impulsive versus sensation-seeking personality traits. Biol Psychiatry (2010) 68:770-3. doi:10.1016/j.biopsych.2010.06.015
228. Dalley JW, Fryer TD, Brichard L, Robinson ES, Theobald DE, Laane K, et al. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science (2007) 315:1267-70. doi:10.1126/science.1137073
229. Belin D, Mar AC, Dalley JW, Robbins TW, Everitt BJ. High impulsivity predicts the switch to compulsive cocaine-taking. Science (2008) 320:1352-5. doi:10.1126/science.1158136
230. Economidou D, Pelloux Y, Robbins TW, Dalley JW, Everitt BJ. High impulsivity predicts relapse to cocaine-seeking after punishment-induced abstinence. Biol Psychiatry (2009) 65:851-6. doi:10.1016/j.biopsych.2008.12.008
231. Radwanska K, Kaczmarek L. Characterization of an alcohol addiction-prone phenotype in mice. Addict Biol (2012) 17:601-12. doi:10.1111/j.1369-1600.2011.00394.x
232. Crews FT, Boettiger CA. Impulsivity, frontal lobes and risk for addiction. Pharmacol Biochem Behav (2009) 93:237-47. doi:10.1016/j.pbb.2009.04.018
233. Robbins TW. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) (2002) 163:362-80. doi:10.1007/s00213-002-1154-7
234. Winstanley CA. The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders. Br J Pharmacol (2011) 164:1301-21. doi:10.1111/j.1476-5381.2011.01323.x
235. Batra A, Collins SE, Torchalla I, Schroter M, Buchkremer G. Multidimensional smoker profiles and their prediction of smoking following a pharmacobehavioral intervention. J Subst Abuse Treat (2008) 35:41-52. doi:10.1016/j.jsat.2007.08.006
236. Piazza PV, Deminiere JM, Le Moal M, Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science (1989) 245:1511-3. doi:10.1126/science.2781295
237. Blanchard MM, Mendelsohn D, Stamp JA. The HR/LR model: further evidence as an animal model of sensation seeking. Neurosci Biobehav Rev (2009) 33:1145-54. doi:10.1016/j.neubiorev.2009.05.009
238. Nesil T, Yararbas G, Mola G, Kanit L, Pogun S. Previous chronic exposure eliminates the conditioning effect of nicotine in rats. Brain Res Bull (2011) 85:339-45. doi:10.1016/j.brainresbull.2011.05.011
239. Cain ME, Saucier DA, Bardo MT. Novelty seeking and drug use: contribution of an animal model. Exp Clin Psychopharmacol (2005) 13:367-75. doi:10.1037/1064-1297.13.4.367
240. Belin D, Deroche-Gamonet V. Responses to novelty and vulnerability to cocaine addiction: contribution of a multi-symptomatic animal model. Cold Spring Harb Perspect Med (2012) 2(11). doi:10.1101/cshperspect.a011940
241. Redolat R, Perez-Martinez A, Carrasco MC, Mesa P. Individual differences in novelty-seeking and behavioral responses to nicotine: a review of animal studies. Curr Drug Abuse Rev (2009) 2:230-42. doi:10.2174/1874473710902030230
242. Gyekis J, Foreman JE, Anthony K, Klein LC, Vandenbergh DJ. Activity-related behaviors in the hole-board predict nicotine consumption in C57B6 mice perinatally exposed to nicotine. Behav Brain Res (2010) 206:139-42. doi:10.1016/j.bbr.2009.08.024
243. Belin D, Berson N, Balado E, Piazza PV, Deroche-Gamonet V. High-novelty-preference rats are predisposed to compulsive cocaine self-administration. Neuropsychopharmacology (2011) 36:569-79. doi:10.1038/npp.2010.188
244. Caille S, Clemens K, Stinus L, Cador M. Modeling nicotine addiction in rats. Methods Mol Biol (2012) 829:243-56. doi:10.1007/978-1-61779-458-2_15
245. Cohen A, Koob GF, George O. Robust escalation of nicotine intake with extended access to nicotine self-administration and intermittent periods of abstinence. Neuropsychopharmacology (2012) 37:2153-60. doi:10.1038/npp.2012.67
246. Clemens KJ, Castino MR, Cornish JL, Goodchild AK, Holmes NM. Behavioral and neural substrates of habit formation in rats intravenously self-administering nicotine. Neuropsychopharmacology (2014) 39:2584-93. doi:10.1038/npp.2014.111
247. Gilpin NW, Whitaker AM, Baynes B, Abdel AY, Weil MT, George O. Nicotine vapor inhalation escalates nicotine self-administration. Addict Biol (2014) 19:587-92. doi:10.1111/adb.12021
248. Linares Scott TJ, Heil SH, Higgins ST, Badger GJ, Bernstein IM. Depressive symptoms predict smoking status among pregnant women. Addict Behav (2009) 34:705-8. doi:10.1016/j.addbeh.2009.04.003
249. Kushner MG, Menary KR, Maurer EW, Thuras P. Greater elevation in risk for nicotine dependence per pack of cigarettes smoked among those with an anxiety disorder. J Stud Alcohol Drugs (2012) 73:920-4. doi:10.15288/jsad.2012.73.920
250. Picciotto MR, Lewis AS, van Schalkwyk GI, Mineur YS. Mood and anxiety regulation by nicotinic acetylcholine receptors: a potential pathway to modulate aggression and related behavioral states. Neuropharmacology (2015) 96:235-43. doi:10.1016/j.neuropharm.2014.12.028
251. Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry (1985) 142:1259-64. doi:10.1176/ajp.142.11.1259
252. Lejuez CW, Zvolensky MJ, Daughters SB, Bornovalova MA, Paulson A, Tull MT, et al. Anxiety sensitivity: a unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatment. Behav Res Ther (2008) 46:811-8. doi:10.1016/j.brat.2008.03.010
253. Khantzian EJ. Addiction as a self-regulation disorder and the role of self-medication. Addiction (2013) 108:668-9. doi:10.1111/add.12004
254. Benowitz NL. Neurobiology of nicotine addiction: implications for smoking cessation treatment. Am J Med (2008) 121:S3-10. doi:10.1016/j.amjmed.2008.01.015
255. Carobrez AP, Bertoglio LJ. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev (2005) 29:1193-205. doi:10.1016/j.neubiorev.2005.04.017
256. Brielmaier J, McDonald CG, Smith RF. Effects of acute stress on acquisition of nicotine conditioned place preference in adolescent rats: a role for corticotropin-releasing factor 1 receptors. Psychopharmacology (Berl) (2012) 219:73-82. doi:10.1007/s00213-011-2378-1
257. Said N, Lakehayli S, El Khachibi M, El Ouahli M, Nadifi S, Hakkou F, et al. Effect of prenatal stress on memory, nicotine withdrawal and 5HT1A expression in raphe nuclei of adult rats. Int J Dev Neurosci (2015) 43:92-8. doi:10.1016/j.ijdevneu.2015.04.008
258. Said N, Lakehayli S, El Khachibi M, El Ouahli M, Nadifi S, Hakkou F, et al. Prenatal stress induces vulnerability to nicotine addiction and alters D2 receptors' expression in the nucleus accumbens in adult rats. Neuroscience (2015) 304:279-85. doi:10.1016/j.neuroscience.2015.07.029
259. Papp M, Gruca P, Lason-Tyburkiewicz M, Litwa E, Willner P. Effects of chronic mild stress on the development of drug dependence in rats. Behav Pharmacol (2014) 25:518-31. doi:10.1097/FBP.0000000000000046
260. Hall FS, Der-Avakian A, Gould TJ, Markou A, Shoaib M, Young JW. Negative affective states and cognitive impairments in nicotine dependence. Neurosci Biobehav Rev (2015) 58:168-85. doi:10.1016/j.neubiorev.2015.06.004
261. Kayir H, Goktalay G, Yavuz O, Uzbay TI. Impact of baseline prepulse inhibition on nicotine-induced locomotor sensitization in rats. Behav Brain Res (2011) 216:275-80. doi:10.1016/j.bbr.2010.08.004
262. Berg SA, Sentir AM, Cooley BS, Engleman EA, Chambers RA. Nicotine is more addictive, not more cognitively therapeutic in a neurodevelopmental model of schizophrenia produced by neonatal ventral hippocampal lesions. Addict Biol (2014) 19:1020-31. doi:10.1111/adb.12082
263. Chen H, Hiler KA, Tolley EA, Matta SG, Sharp BM. Genetic factors control nicotine self-administration in isogenic adolescent rat strains. PLoS One (2012) 7:e44234. doi:10.1371/journal.pone.0044234
264. Watterson E, Daniels CW, Watterson LR, Mazur GJ, Brackney RJ, Olive MF, et al. Nicotine-induced place conditioning and locomotor activity in an adolescent animal model of attention deficit/hyperactivity disorder (ADHD). Behav Brain Res (2015) 291:184-8. doi:10.1016/j.bbr.2015.05.031
265. Stead JD, Clinton S, Neal C, Schneider J, Jama A, Miller S, et al. Selective breeding for divergence in novelty-seeking traits: heritability and enrichment in spontaneous anxiety-related behaviors. Behav Genet (2006) 36:697-712. doi:10.1007/s10519-006-9058-7
266. Mirza NR, Stolerman IP. Nicotine enhances sustained attention in the rat under specific task conditions. Psychopharmacology (Berl) (1998) 138:266-74. doi:10.1007/s002130050671
267. Stolerman IP, Mirza NR, Hahn B, Shoaib M. Nicotine in an animal model of attention. Eur J Pharmacol (2000) 393:147-54. doi:10.1016/S0014-2999(99)00886-9
268. Blondel A, Sanger DJ, Moser PC. Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies. Psychopharmacology (Berl) (2000) 149:293-305. doi:10.1007/s002130000378
269. Bizarro L, Patel S, Murtagh C, Stolerman IP. Differential effects of psychomotor stimulants on attentional performance in rats: nicotine, amphetamine, caffeine and methylphenidate. Behav Pharmacol (2004) 15:195-206.
270. van Gaalen MM, Brueggeman RJ, Bronius PF, Schoffelmeer AN, Vanderschuren LJ. Behavioral disinhibition requires dopamine receptor activation. Psychopharmacology (Berl) (2006) 187:73-85. doi:10.1007/s00213-006-0396-1
271. Semenova S, Stolerman IP, Markou A. Chronic nicotine administration improves attention while nicotine withdrawal induces performance deficits in the 5-choice serial reaction time task in rats. Pharmacol Biochem Behav (2007) 87:360-8. doi:10.1016/j.pbb.2007.05.009
272. Tsutsui-Kimura I, Ohmura Y, Izumi T, Yamaguchi T, Yoshida T, Yoshioka M. Nicotine provokes impulsive-like action by stimulating alpha4beta2 nicotinic acetylcholine receptors in the infralimbic, but not in the prelimbic cortex. Psychopharmacology (Berl) (2010) 209:351-9. doi:10.1007/s00213-010-1804-0
273. Kolokotroni KZ, Rodgers RJ, Harrison AA. Acute nicotine increases both impulsive choice and behavioural disinhibition in rats. Psychopharmacology (Berl) (2011) 217:455-73. doi:10.1007/s00213-011-2296-2
274. Grottick AJ, Higgins GA. Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task. Behav Brain Res (2000) 117:197-208. doi:10.1016/S0166-4328(00)00305-3
275. Counotte DS, Spijker S, Van de Burgwal LH, Hogenboom F, Schoffelmeer AN, De Vries TJ, et al. Long-lasting cognitive deficits resulting from adolescent nicotine exposure in rats. Neuropsychopharmacology (2009) 34:299-306. doi:10.1038/npp.2008.96
276. Kirshenbaum AP, Jackson ER, Brown SJ, Fuchs JR, Miltner BC, Doughty AH. Nicotine-induced impulsive action: sensitization and attenuation by mecamylamine. Behav Pharmacol (2011) 22:207-21. doi:10.1097/FBP.0b013e328345ca1c
277. Dallery J, Locey ML. Effects of acute and chronic nicotine on impulsive choice in rats. Behav Pharmacol (2005) 16:15-23. doi:10.1097/00008877-200502000-00002
278. Kelsey JE, Niraula A. Effects of acute and sub-chronic nicotine on impulsive choice in rats in a probabilistic delay-discounting task. Psychopharmacology (Berl) (2013) 227:385-92. doi:10.1007/s00213-013-2984-1
279. Anderson KG, Diller JW. Effects of acute and repeated nicotine administration on delay discounting in Lewis and Fischer 344 rats. Behav Pharmacol (2010) 21:754-64. doi:10.1097/FBP.0b013e328340a050
280. O'Neill AB, Brioni JD. Benzodiazepine receptor mediation of the anxiolytic-like effect of (-)-nicotine in mice. Pharmacol Biochem Behav (1994) 49:755-7. doi:10.1016/0091-3057(94)90097-3
281. File SE, Kenny PJ, Ouagazzal AM. Bimodal modulation by nicotine of anxiety in the social interaction test: role of the dorsal hippocampus. Behav Neurosci (1998) 112:1423-9. doi:10.1037/0735-7044.112.6.1423
282. Irvine EE, Cheeta S, File SE. Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine. Behav Pharmacol (1999) 10:691-7. doi:10.1097/00008877-199911000-00016
283. Balerio GN, Aso E, Maldonado R. Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice. Psychopharmacology (Berl) (2005) 181:260-9. doi:10.1007/s00213-005-2238-y
284. Balerio GN, Aso E, Maldonado R. Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice. Psychopharmacology (Berl) (2006) 184:504-13. doi:10.1007/s00213-005-0251-9
285. Villegier AS, Gallager B, Heston J, Belluzzi JD, Leslie FM. Age influences the effects of nicotine and monoamine oxidase inhibition on mood-related behaviors in rats. Psychopharmacology (Berl) (2010) 208:593-601. doi:10.1007/s00213-009-1760-8
286. McGranahan TM, Patzlaff NE, Grady SR, Heinemann SF, Booker TK. alpha4beta2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief. J Neurosci (2011) 31:10891-902. doi:10.1523/JNEUROSCI.0937-11.2011
287. Varani AP, Moutinho LM, Bettler B, Balerio GN. Acute behavioural responses to nicotine and nicotine withdrawal syndrome are modified in GABA(B1) knockout mice. Neuropharmacology (2012) 63:863-72. doi:10.1016/j.neuropharm.2012.06.006
288. Ouagazzal AM, Kenny PJ, File SE. Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine. Psychopharmacology (Berl) (1999) 144:54-60. doi:10.1007/s002130050976
289. Irvine EE, Cheeta S, File SE. Tolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal. Pharmacol Biochem Behav (2001) 68:319-25. doi:10.1016/S0091-3057(00)00449-4
290. Biala G, Kruk M. Effects of co-administration of bupropion and nicotine or d-amphetamine on the elevated plus maze test in mice. J Pharm Pharmacol (2009) 61:493-502. doi:10.1211/jpp/61.04.0012
291. Biala G, Kruk M, Budzynska B. Effects of the cannabinoid receptor ligands on anxiety-related effects of d-amphetamine and nicotine in the mouse elevated plus maze test. J Physiol Pharmacol (2009) 60:113-22.
292. Zarrindast MR, Aghamohammadi-Sereshki A, Rezayof A, Rostami P. Nicotine-induced anxiogenic-like behaviours of rats in the elevated plus-maze: possible role of NMDA receptors of the central amygdala. J Psychopharmacol (2012) 26:555-63. doi:10.1177/0269881111412094
293. Ericson M, Olausson P, Engel JA, Soderpalm B. Nicotine induces disinhibitory behavior in the rat after subchronic peripheral nicotinic acetylcholine receptor blockade. Eur J Pharmacol (2000) 397:103-11. doi:10.1016/S0014-2999(00)00191-6
294. Elliott BM, Faraday MM, Phillips JM, Grunberg NE. Effects of nicotine on elevated plus maze and locomotor activity in male and female adolescent and adult rats. Pharmacol Biochem Behav (2004) 77:21-8. doi:10.1016/j.pbb.2003.09.016
295. Irvine EE, Bagnalasta M, Marcon C, Motta C, Tessari M, File SE, et al. Nicotine self-administration and withdrawal: modulation of anxiety in the social interaction test in rats. Psychopharmacology (Berl) (2001) 153:315-20. doi:10.1007/s002130000586
296. Caldarone BJ, King SL, Picciotto MR. Sex differences in anxiety-like behavior and locomotor activity following chronic nicotine exposure in mice. Neurosci Lett (2008) 439:187-91. doi:10.1016/j.neulet.2008.05.023
297. Trigo JM, Zimmer A, Maldonado R. Nicotine anxiogenic and rewarding effects are decreased in mice lacking beta-endorphin. Neuropharmacology (2009) 56:1147-53. doi:10.1016/j.neuropharm.2009.03.013
298. Bura SA, Burokas A, Martin-Garcia E, Maldonado R. Effects of chronic nicotine on food intake and anxiety-like behaviour in CB(1) knockout mice. Eur Neuropsychopharmacol (2010) 20:369-78. doi:10.1016/j.euroneuro.2010.02.003
299. Besson M, Suarez S, Cormier A, Changeux JP, Granon S. Chronic nicotine exposure has dissociable behavioural effects on control and beta2-/-mice. Behav Genet (2008) 38:503-14. doi:10.1007/s10519-008-9216-1
300. Ijomone OM, Olaibi OK, Mba C, Biose IJ, Tete SA, Nwoha PU. Chronic nicotine administration does not alter cognitive or mood associated behavioural parameters. Pathophysiology (2015) 22:57-63. doi:10.1016/j.pathophys.2014.12.004
301. Gould TJ, Wehner JM. Nicotine enhancement of contextual fear conditioning. Behav Brain Res (1999) 102:31-9. doi:10.1016/S0166-4328(98)00157-0
302. Gould TJ. Nicotine produces a within-subject enhancement of contextual fear conditioning in C57BL/6 mice independent of sex. Integr Physiol Behav Sci (2003) 38:124-32. doi:10.1007/BF02688830
303. Gould TJ, Higgins JS. Nicotine enhances contextual fear conditioning in C57BL/6J mice at 1 and 7 days post-training. Neurobiol Learn Mem (2003) 80:147-57. doi:10.1016/S1074-7427(03)00057-1
304. Gould TJ, Lommock JA. Nicotine enhances contextual fear conditioning and ameliorates ethanol-induced deficits in contextual fear conditioning. Behav Neurosci (2003) 117:1276-82. doi:10.1037/0735-7044.117.6.1276
305. Wehner JM, Keller JJ, Keller AB, Picciotto MR, Paylor R, Booker TK, et al. Role of neuronal nicotinic receptors in the effects of nicotine and ethanol on contextual fear conditioning. Neuroscience (2004) 129:11-24. doi:10.1016/j.neuroscience.2004.07.016
306. Davis JA, James JR, Siegel SJ, Gould TJ. Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice. J Neurosci (2005) 25:8708-13. doi:10.1523/JNEUROSCI.2853-05.2005
307. Davis JA, Porter J, Gould TJ. Nicotine enhances both foreground and background contextual fear conditioning. Neurosci Lett (2006) 394:202-5. doi:10.1016/j.neulet.2005.10.026
308. Portugal GS, Wilkinson DS, Kenney JW, Sullivan C, Gould TJ. Strain-dependent effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning. Behav Genet (2012) 42:133-50. doi:10.1007/s10519-011-9489-7
309. Szyndler J, Sienkiewicz-Jarosz H, Maciejak P, Siemiatkowski M, Rokicki D, Czlonkowska AI, et al. The anxiolytic-like effect of nicotine undergoes rapid tolerance in a model of contextual fear conditioning in rats. Pharmacol Biochem Behav (2001) 69:511-8. doi:10.1016/S0091-3057(01)00548-2
310. Kutlu MG, Oliver C, Gould TJ. The effects of acute nicotine on contextual safety discrimination. J Psychopharmacol (2014) 28:1064-70. doi:10.1177/0269881114552743
311. Tizabi Y, Overstreet DH, Rezvani AH, Louis VA, Clark E Jr, Janowsky DS, et al. Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology (Berl) (1999) 142:193-9. doi:10.1007/s002130050879
312. Vazquez-Palacios G, Bonilla-Jaime H, Velazquez-Moctezuma J. Antidepressant-like effects of the acute and chronic administration of nicotine in the rat forced swimming test and its interaction with fluoxetine [correction of flouxetine]. Pharmacol Biochem Behav (2004) 78:165-9. doi:10.1016/j.pbb.2004.03.002
313. Suemaru K, Yasuda K, Cui R, Li B, Umeda K, Amano M, et al. Antidepressant-like action of nicotine in forced swimming test and brain serotonin in mice. Physiol Behav (2006) 88:545-9. doi:10.1016/j.physbeh.2006.05.007
314. Andreasen JT, Redrobe JP. Antidepressant-like effects of nicotine and mecamylamine in the mouse forced swim and tail suspension tests: role of strain, test and sex. Behav Pharmacol (2009) 20:286-95. doi:10.1097/FBP.0b013e32832c713e
315. Tizabi Y, Getachew B, Rezvani AH, Hauser SR, Overstreet DH. Antidepressant-like effects of nicotine and reduced nicotinic receptor binding in the Fawn-hooded rat, an animal model of co-morbid depression and alcoholism. Prog Neuropsychopharmacol Biol Psychiatry (2009) 33:398-402. doi:10.1016/j.pnpbp.2008.09.010
316. Semba J, Mataki C, Yamada S, Nankai M, Toru M. Antidepressantlike effects of chronic nicotine on learned helplessness paradigm in rats. Biol Psychiatry (1998) 43:389-91. doi:10.1016/S0006-3223(97)00477-0
317. Djuric VJ, Dunn E, Overstreet DH, Dragomir A, Steiner M. Antidepressant effect of ingested nicotine in female rats of Flinders resistant and sensitive lines. Physiol Behav (1999) 67:533-7. doi:10.1016/S0031-9384(99)00091-8
318. Tizabi Y, Hauser SR, Tyler KY, Getachew B, Madani R, Sharma Y, et al. Effects of nicotine on depressive-like behavior and hippocampal volume of female WKY rats. Prog Neuropsychopharmacol Biol Psychiatry (2010) 34:62-9. doi:10.1016/j.pnpbp.2009.09.024
319. Puma C, Deschaux O, Molimard R, Bizot JC. Nicotine improves memory in an object recognition task in rats. Eur Neuropsychopharmacol (1999) 9:323-7. doi:10.1016/S0924-977X(99)00002-4
320. Levin ED, Kaplan S, Boardman A. Acute nicotine interactions with nicotinic and muscarinic antagonists: working and reference memory effects in the 16-arm radial maze. Behav Pharmacol (1997) 8:236-42.
321. Levin ED, Weber E, Icenogle L. Baclofen interactions with nicotine in rats: effects on memory. Pharmacol Biochem Behav (2004) 79:343-8. doi:10.1016/j.pbb.2004.08.013
322. Moragrega I, Carrasco MC, Vicens P, Redolat R. Spatial learning in male mice with different levels of aggressiveness: effects of housing conditions and nicotine administration. Behav Brain Res (2003) 147:1-8. doi:10.1016/S0166-4328(03)00112-8
323. Levin ED, Lee C, Rose JE, Reyes A, Ellison G, Jarvik M, et al. Chronic nicotine and withdrawal effects on radial-arm maze performance in rats. Behav Neural Biol (1990) 53:269-76. doi:10.1016/0163-1047(90)90509-5
324. Levin ED, Briggs SJ, Christopher NC, Rose JE. Persistence of chronic nicotine-induced cognitive facilitation. Behav Neural Biol (1992) 58:152-8. doi:10.1016/0163-1047(92)90399-O
325. Levin ED, Christopher NC, Briggs SJ, Rose JE. Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basalocortical projection. Brain Res Cogn Brain Res (1993) 1:137-43. doi:10.1016/0926-6410(93)90021-V
326. Arendash GW, Sanberg PR, Sengstock GJ. Nicotine enhances the learning and memory of aged rats. Pharmacol Biochem Behav (1995) 52:517-23. doi:10.1016/0091-3057(95)00119-H
327. Socci DJ, Sanberg PR, Arendash GW. Nicotine enhances Morris water maze performance of young and aged rats. Neurobiol Aging (1995) 16:857-60. doi:10.1016/0197-4580(95)00091-R
328. Levin ED, Torry D. Acute and chronic nicotine effects on working memory in aged rats. Psychopharmacology (Berl) (1996) 123:88-97. doi:10.1007/BF02246285
329. Yilmaz O, Kanit L, Okur BE, Pogun S. Effects of nicotine on active avoidance learning in rats: sex differences. Behav Pharmacol (1997) 8:253-60.
330. Attaway CM, Compton DM, Turner MD. The effects of nicotine on learning and memory: a neuropsychological assessment in young and senescent Fischer 344 rats. Physiol Behav (1999) 67:421-31. doi:10.1016/S0031-9384(99)00081-5
331. Levin ED, Christopher NC, Weaver T, Moore J, Brucato F. Ventral hippocampal ibotenic acid lesions block chronic nicotine-induced spatial working memory improvement in rats. Brain Res Cogn Brain Res (1999) 7:405-10. doi:10.1016/S0926-6410(98)00044-5
332. Ciamei A, Aversano M, Cestari V, Castellano C. Effects of MK-801 and nicotine combinations on memory consolidation in CD1 mice. Psychopharmacology (Berl) (2001) 154:126-30. doi:10.1007/s002130000584
333. Vicens P, Carrasco MC, Redolat R. Effects of early training and nicotine treatment on the performance of male NMRI mice in the water maze. Neural Plast (2003) 10:303-17. doi:10.1155/NP.2003.303
334. Blondel A, Simon H, Sanger DJ, Moser P. The effect of repeated nicotine administration on the performance of drug-naive rats in a five-choice serial reaction time task. Behav Pharmacol (1999) 10:665-73. doi:10.1097/00008877-199911000-00013
335. Grilly DM. A verification of psychostimulant-induced improvement in sustained attention in rats: effects of d-amphetamine, nicotine, and pemoline. Exp Clin Psychopharmacol (2000) 8:14-21. doi:10.1037/1064-1297.8.1.14
336. Grilly DM, Simon BB, Levin ED. Nicotine enhances stimulus detection performance of middle-and old-aged rats: a longitudinal study. Pharmacol Biochem Behav (2000) 65:665-70. doi:10.1016/S0091-3057(99)00259-2
337. Mirza NR, Bright JL. Nicotine-induced enhancements in the five-choice serial reaction time task in rats are strain-dependent. Psychopharmacology (Berl) (2001) 154:8-12. doi:10.1007/s002130000605
338. Bizarro L, Stolerman IP. Attentional effects of nicotine and amphetamine in rats at different levels of motivation. Psychopharmacology (Berl) (2003) 170:271-7. doi:10.1007/s00213-003-1543-6
339. Quarta D, Naylor CG, Morris HV, Patel S, Genn RF, Stolerman IP. Different effects of ionotropic and metabotropic glutamate receptor antagonists on attention and the attentional properties of nicotine. Neuropharmacology (2007) 53:421-30. doi:10.1016/j.neuropharm.2007.05.023
340. Hahn B, Stolerman IP. Nicotine-induced attentional enhancement in rats: effects of chronic exposure to nicotine. Neuropsychopharmacology (2002) 27:712-22. doi:10.1016/S0893-133X(02)00348-2
341. Hahn B, Shoaib M, Stolerman IP. Nicotine-induced enhancement of attention in the five-choice serial reaction time task: the influence of task demands. Psychopharmacology (Berl) (2002) 162:129-37. doi:10.1007/s00213-002-1005-6
342. Mendez IA, Gilbert RJ, Bizon JL, Setlow B. Effects of acute administration of nicotinic and muscarinic cholinergic agonists and antagonists on performance in different cost-benefit decision making tasks in rats. Psychopharmacology (Berl) (2012) 224:489-99. doi:10.1007/s00213-012-2777-y
343. Mitchell MR, Mendez IA, Vokes CM, Damborsky JC, Winzer-Serhan UH, Setlow B. Effects of developmental nicotine exposure in rats on decision-making in adulthood. Behav Pharmacol (2012) 23:34-42. doi:10.1097/FBP.0b013e32834eb04a
344. Ortega LA, Tracy BA, Gould TJ, Parikh V. Effects of chronic low-and high-dose nicotine on cognitive flexibility in C57BL/6J mice. Behav Brain Res (2013) 238:134-45. doi:10.1016/j.bbr.2012.10.032
345. Cole RD, Poole RL, Guzman DM, Gould TJ, Parikh V. Contributions of beta2 subunit-containing nAChRs to chronic nicotine-induced alterations in cognitive flexibility in mice. Psychopharmacology (Berl) (2015) 232:1207-17. doi:10.1007/s00213-014-3754-4
346. Allison C, Shoaib M. Nicotine improves performance in an attentional set shifting task in rats. Neuropharmacology (2013) 64:314-20. doi:10.1016/j.neuropharm.2012.06.055
347. Wood C, Kohli S, Malcolm E, Allison C, Shoaib M. Subtype-selective nicotinic acetylcholine receptor agonists can improve cognitive flexibility in an attentional set shifting task. Neuropharmacology (2016) 105:106-13. doi:10.1016/j.neuropharm.2016.01.006
348. Perry JL, Carroll ME. The role of impulsive behavior in drug abuse. Psychopharmacology (Berl) (2008) 200:1-26. doi:10.1007/s00213-008-1173-0
349. Scott D, Taylor JR. Chronic nicotine attenuates phencyclidine-induced impulsivity in a mouse serial reaction time task. Behav Brain Res (2014) 259:164-73. doi:10.1016/j.bbr.2013.11.009
350. Schneider T, Ilott N, Brolese G, Bizarro L, Asherson PJ, Stolerman IP. Prenatal exposure to nicotine impairs performance of the 5-choice serial reaction time task in adult rats. Neuropsychopharmacology (2011) 36:1114-25. doi:10.1038/npp.2010.249
351. Schneider T, Bizarro L, Asherson PJ, Stolerman IP. Hyperactivity, increased nicotine consumption and impaired performance in the five-choice serial reaction time task in adolescent rats prenatally exposed to nicotine. Psychopharmacology (Berl) (2012) 223:401-15. doi:10.1007/s00213-012-2728-7
352. Kayir H, Semenova S, Markou A. Baseline impulsive choice predicts the effects of nicotine and nicotine withdrawal on impulsivity in rats. Prog Neuropsychopharmacol Biol Psychiatry (2014) 48:6-13. doi:10.1016/j.pnpbp.2013.09.007
353. Kutlu MG, Gould TJ. Nicotine modulation of fear memories and anxiety: implications for learning and anxiety disorders. Biochem Pharmacol (2015) 97:498-511. doi:10.1016/j.bcp.2015.07.029
354. Le Foll B, Ng E, Di Ciano P, Trigo JM. Psychiatric disorders as vulnerability factors for nicotine addiction: what have we learned from animal models? Curr Top Behav Neurosci (2015) 24:155-70. doi:10.1007/978-3-319-13482-6_6
355. Vinkers CH, de Jong NM, Kalkman CJ, Westphal KG, van Oorschot R, Olivier B, et al. Stress-induced hyperthermia is reduced by rapid-acting anxiolytic drugs independent of injection stress in rats. Pharmacol Biochem Behav (2009) 93:413-8. doi:10.1016/j.pbb.2009.05.017
356. Salas R, Main A, Gangitano DA, Zimmerman G, Ben-Ari S, Soreq H, et al. Nicotine relieves anxiogenic-like behavior in mice that overexpress the read-through variant of acetylcholinesterase but not in wild-type mice. Mol Pharmacol (2008) 74:1641-8. doi:10.1124/mol.108.048454
357. Andreasen JT, Henningsen K, Bate S, Christiansen S, Wiborg O. Nicotine reverses anhedonic-like response and cognitive impairment in the rat chronic mild stress model of depression: comparison with sertraline. J Psychopharmacol (2011) 25:1134-41. doi:10.1177/0269881110391831
358. Bhattacharya SK, Chakrabarti A, Sandler M, Glover V. Rat brain monoamine oxidase A and B inhibitory (tribulin) activity during drug withdrawal anxiety. Neurosci Lett (1995) 199:103-6. doi:10.1016/0304-3940(95)12032-Y
359. Damaj MI, Kao W, Martin BR. Characterization of spontaneous and precipitated nicotine withdrawal in the mouse. J Pharmacol Exp Ther (2003) 307:526-34. doi:10.1124/jpet.103.054908
360. Biala G, Weglinska B. Blockade of the expression of mecamylamine-precipitated nicotine withdrawal by calcium channel antagonists. Pharmacol Res (2005) 51:483-8. doi:10.1016/j.phrs.2004.11.009
361. Stoker AK, Semenova S, Markou A. Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice. Neuropharmacology (2008) 54:1223-32. doi:10.1016/j.neuropharm.2008.03.013
362. Jonkman S, Risbrough VB, Geyer MA, Markou A. Spontaneous nicotine withdrawal potentiates the effects of stress in rats. Neuropsychopharmacology (2008) 33:2131-8. doi:10.1038/sj.npp.1301607
363. Gould TJ, Leach PT. Cellular, molecular, and genetic substrates underlying the impact of nicotine on learning. Neurobiol Learn Mem (2014) 107:108-32. doi:10.1016/j.nlm.2013.08.004
364. Elias GA, Gulick D, Wilkinson DS, Gould TJ. Nicotine and extinction of fear conditioning. Neuroscience (2010) 165:1063-73. doi:10.1016/j.neuroscience.2009.11.022
365. Tian S, Gao J, Han L, Fu J, Li C, Li Z. Prior chronic nicotine impairs cued fear extinction but enhances contextual fear conditioning in rats. Neuroscience (2008) 153:935-43. doi:10.1016/j.neuroscience.2008.03.005
366. Andreasen JT, Nielsen EO, Redrobe JP. Chronic oral nicotine increases brain [3H]epibatidine binding and responsiveness to antidepressant drugs, but not nicotine, in the mouse forced swim test. Psychopharmacology (Berl) (2009) 205:517-28. doi:10.1007/s00213-009-1560-1
367. Hayase T. Depression-related anhedonic behaviors caused by immobilization stress: a comparison with nicotine-induced depression-like behavioral alterations and effects of nicotine and/or "antidepressant" drugs. J Toxicol Sci (2011) 36:31-41. doi:10.2131/jts.36.31
368. Vazquez-Palacios G, Bonilla-Jaime H, Velazquez-Moctezuma J. Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine. Prog Neuropsychopharmacol Biol Psychiatry (2005) 29:39-46. doi:10.1016/j.pnpbp.2004.08.008
369. Vieyra-Reyes P, Mineur YS, Picciotto MR, Tunez I, Vidaltamayo R, Drucker-Colin R. Antidepressant-like effects of nicotine and transcranial magnetic stimulation in the olfactory bulbectomy rat model of depression. Brain Res Bull (2008) 77:13-8. doi:10.1016/j.brainresbull.2008.05.007
370. Epping-Jordan MP, Watkins SS, Koob GF, Markou A. Dramatic decreases in brain reward function during nicotine withdrawal. Nature (1998) 393:76-9. doi:10.1038/30001
371. Harrison AA, Liem YT, Markou A. Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats. Neuropsychopharmacology (2001) 25:55-71. doi:10.1016/S0893-133X(00)00237-2
372. Rezvani AH, Levin ED. Cognitive effects of nicotine. Biol Psychiatry (2001) 49:258-67. doi:10.1016/S0006-3223(00)01094-5
373. Kenney JW, Gould TJ. Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine. Mol Neurobiol (2008) 38:101-21. doi:10.1007/s12035-008-8037-9
374. Meguro K, Yamaguchi S, Arai H, Nakagawa T, Doi C, Yamada M, et al. Nicotine improves cognitive disturbance in senescence-accelerated mice. Pharmacol Biochem Behav (1994) 49:769-72. doi:10.1016/0091-3057(94)90100-7
375. Woodruff-Pak DS. Mecamylamine reversal by nicotine and by a partial alpha7 nicotinic acetylcholine receptor agonist (GTS-21) in rabbits tested with delay eyeblink classical conditioning. Behav Brain Res (2003) 143:159-67. doi:10.1016/S0166-4328(03)00039-1
376. Zhou M, Suszkiw JB. Nicotine attenuates spatial learning deficits induced in the rat by perinatal lead exposure. Brain Res (2004) 999:142-7. doi:10.1016/j.brainres.2003.10.068
377. Grigoryan GA, Mitchell SN, Hodges H, Sinden JD, Gray JA. Are the cognitive-enhancing effects of nicotine in the rat with lesions to the forebrain cholinergic projection system mediated by an interaction with the noradrenergic system? Pharmacol Biochem Behav (1994) 49:511-21. doi:10.1016/0091-3057(94)90063-9
378. Hiramatsu M, Yamatsu T, Kameyama T, Nabeshima T. Effects of repeated administration of (-)-nicotine on AF64A-induced learning and memory impairment in rats. J Neural Transm (Vienna) (2002) 109:361-75. doi:10.1007/s007020200029
379. Portugal GS, Gould TJ. Nicotine withdrawal disrupts new contextual learning. Pharmacol Biochem Behav (2009) 92:117-23. doi:10.1016/j.pbb.2008.11.001
380. Raybuck JD, Gould TJ. Nicotine withdrawal-induced deficits in trace fear conditioning in C57BL/6 mice-a role for high-affinity beta2 subunit-containing nicotinic acetylcholine receptors. Eur J Neurosci (2009) 29:377-87. doi:10.1111/j.1460-9568.2008.06580.x
381. Muir JL, Everitt BJ, Robbins TW. Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron. Psychopharmacology (Berl) (1995) 118:82-92. doi:10.1007/BF02245253
382. Rezvani AH, Levin ED. Nicotine-antipsychotic drug interactions and attentional performance in female rats. Eur J Pharmacol (2004) 486:175-82. doi:10.1016/j.ejphar.2003.12.021
383. Shoaib M, Bizarro L. Deficits in a sustained attention task following nicotine withdrawal in rats. Psychopharmacology (Berl) (2005) 178:211-22. doi:10.1007/s00213-004-2004-6
384. Semenova S, Bespalov A, Markou A. Decreased prepulse inhibition during nicotine withdrawal in DBA/2J mice is reversed by nicotine self-administration. Eur J Pharmacol (2003) 472:99-110. doi:10.1016/S0014-2999(03)01904-6
385. Andre JM, Gulick D, Portugal GS, Gould TJ. Nicotine withdrawal disrupts both foreground and background contextual fear conditioning but not pre-pulse inhibition of the acoustic startle response in C57BL/6 mice. Behav Brain Res (2008) 190:174-81. doi:10.1016/j.bbr.2008.02.018
386. Belin D, Belin-Rauscent A, Murray JE, Everitt BJ. Addiction: failure of control over maladaptive incentive habits. Curr Opin Neurobiol (2013) 23:564-72. doi:10.1016/j.conb.2013.01.025